These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

412 related articles for article (PubMed ID: 15586648)

  • 21. Diabetic nephropathy: early detection, prevention and management.
    Maher JF
    Am Fam Physician; 1992 Apr; 45(4):1661-8. PubMed ID: 1558042
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Risk factors of diabetic nephropathy progression in patients with a long history of diabetic mellitus as shown by a retrospective analysis].
    Shestakova MV; Koshel' LV; Vagodin VA; Dedov II
    Ter Arkh; 2006; 78(5):60-4. PubMed ID: 16889052
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Diabetic macular edema and its relationship to renal microangiopathy: a sample of Type I diabetes mellitus patients in a 15-year follow-up study.
    Romero P; Baget M; Mendez I; Fernández J; Salvat M; Martinez I
    J Diabetes Complications; 2007; 21(3):172-80. PubMed ID: 17493551
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Diabetic nephropathy in type 2 diabetes--epidemiology, early diagnosis and therapeutic strategies].
    Schernthaner G
    Klin Wochenschr; 1992; 69 Suppl 29():28-34. PubMed ID: 1614188
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Controversies on the pathogenesis of diabetic angiopathy: which treatment for normotensive adolescents with microalbuminuria and type 1 diabetes?
    Danne T; Kordonouri O
    J Pediatr Endocrinol Metab; 1998 Apr; 11 Suppl 2():347-63. PubMed ID: 9642665
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Current concepts in the management of diabetic nephropathy.
    Waanders F; Visser FW; Gans RO
    Neth J Med; 2013 Nov; 71(9):448-58. PubMed ID: 24218418
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Signs of nephropathy may occur early in young adults with diabetes despite modern diabetes management: results from the nationwide population-based Diabetes Incidence Study in Sweden (DISS).
    Svensson M; Sundkvist G; Arnqvist HJ; Björk E; Blohmé G; Bolinder J; Henricsson M; Nyström L; Torffvit O; Waernbaum I; Ostman J; Eriksson JW;
    Diabetes Care; 2003 Oct; 26(10):2903-9. PubMed ID: 14514599
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Benefits and cost of antihypertensive treatment in incipient and overt diabetic nephropathy.
    Parving HH
    J Hypertens Suppl; 1998 Jan; 16(1):S99-101. PubMed ID: 9534107
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Diabetic nephropathy: diagnosis and therapy].
    Hasslacher C
    Ther Umsch; 1996 Dec; 53(12):943-7. PubMed ID: 9036572
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Etiology, diagnosis, and prevention of renal involvement in insulin-dependent diabetes mellitus.
    Chiumello G; Beccaria L; Meschi F; Mistura L; Brambilla P; Bognetti E
    Pediatrician; 1983-1985; 12(4):199-207. PubMed ID: 6400450
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Diabetic nephropathy.
    Boner G; Cooper ME
    Diabetes Technol Ther; 1999; 1(4):489-96. PubMed ID: 11474836
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Diabetic nephropathy: diagnosis, prevention, and treatment.
    Gross JL; de Azevedo MJ; Silveiro SP; Canani LH; Caramori ML; Zelmanovitz T
    Diabetes Care; 2005 Jan; 28(1):164-76. PubMed ID: 15616252
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Diabetic nephropathy in children and adolescents and its consequences in adults.
    Koulouridis E
    J Pediatr Endocrinol Metab; 2001; 14 Suppl 5():1367-77. PubMed ID: 11964036
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Diabetic nephropathy; clinical stage and prediction].
    Kaizu K; Komine N
    Rinsho Byori; 2001 Dec; 49(12):1205-11. PubMed ID: 11797389
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Diabetic nephropathy--screening, follow-up and treatment. Nephropathy Study Groups of The Finnish Diabetes Organization].
    Koivisto V; Groop PH; Huttunen NP; Kivekäs J; Pasternack A; Uusitupa M; Viikari J
    Nord Med; 1997 May; 112(5):154-62. PubMed ID: 9273505
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Use of losartan in reducing microalbuminuria in normotensive patients with type-2 diabetes mellitus.
    Agha A; Bashir K; Anwar E
    Nepal Med Coll J; 2007 Jun; 9(2):79-83. PubMed ID: 17899953
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Renal function preservation in type 2 diabetes mellitus patients with early nephropathy: a comparative prospective cohort study between primary health care doctors and a nephrologist.
    Martínez-Ramírez HR; Jalomo-Martínez B; Cortés-Sanabria L; Rojas-Campos E; Barragán G; Alfaro G; Cueto-Manzano AM
    Am J Kidney Dis; 2006 Jan; 47(1):78-87. PubMed ID: 16377388
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Risk factors for development and progression of diabetic kidney disease and treatment patterns among diabetic siblings of patients with diabetic kidney disease.
    Bleyer AJ; Sedor JR; Freedman BI; O'Brien A; Russell GB; Graley J; Schelling JR
    Am J Kidney Dis; 2008 Jan; 51(1):29-37. PubMed ID: 18155530
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Diabetic nephropathy: worldwide epidemic and effects of current treatment on natural history.
    Rossing P
    Curr Diab Rep; 2006 Dec; 6(6):479-83. PubMed ID: 17118233
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prevalence of dyslipidemia among adult diabetic patients with overt diabetic nephropathy in Anambra state south-east Nigeria.
    Jisieike-Onuigbo NN; Unuigbe EI; Kalu OA; Oguejiofor CO; Onuigbo PC
    Niger J Clin Pract; 2011; 14(2):171-5. PubMed ID: 21860134
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.